Maximus, Inc. (NYSE:MMS – Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $97.41 and last traded at $96.8170, with a volume of 19430 shares changing hands. The stock had previously closed at $96.59.
Analyst Ratings Changes
A number of equities analysts recently weighed in on MMS shares. Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a research report on Monday, December 29th. Zacks Research raised shares of Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to MarketBeat, Maximus currently has a consensus rating of “Strong Buy”.
Check Out Our Latest Stock Report on Maximus
Maximus Stock Down 0.1%
Maximus (NYSE:MMS – Get Free Report) last announced its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. Maximus had a return on equity of 25.23% and a net margin of 5.87%.The firm’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be given a $0.33 dividend. This is an increase from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date is Friday, February 13th. Maximus’s dividend payout ratio (DPR) is presently 21.58%.
Insider Buying and Selling at Maximus
In other news, insider Michelle F. Link sold 4,039 shares of the stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $86.84, for a total transaction of $350,746.76. Following the completion of the transaction, the insider directly owned 19,542 shares in the company, valued at approximately $1,697,027.28. This represents a 17.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.60% of the company’s stock.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. Richardson Financial Services Inc. increased its position in shares of Maximus by 123.1% during the third quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 192 shares during the last quarter. Advisory Services Network LLC acquired a new stake in Maximus in the 3rd quarter valued at approximately $32,000. Cullen Frost Bankers Inc. acquired a new stake in Maximus in the 3rd quarter valued at approximately $38,000. Canada Pension Plan Investment Board purchased a new stake in Maximus in the second quarter valued at approximately $35,000. Finally, Danske Bank A S purchased a new stake in shares of Maximus in the 3rd quarter valued at $55,000. Institutional investors and hedge funds own 97.21% of the company’s stock.
About Maximus
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Further Reading
- Five stocks we like better than Maximus
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
